DVAX Competitors & Alternatives
Compare Dynavax Technologies Corporation with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
DVAX
Main Stock$15.50
Tradestie Score
48
Market Cap
$1.21B
Revenue Growth
0.2%
Analyst Upside
+41.9%
Top Competitors
44 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANIP
ANI Pharmaceuticals, Inc.
|
$71.06
|
$2.01B | 14.1 | 51 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$58.12
|
$1.90B | - | 35 | Compare |
|
HROW
Harrow, Inc. Common Stock
|
$28.30
|
$1.79B | - | 51 | Compare |
|
PAHC
Phibro Animal Health Corporation Class A
|
$35.46
|
$1.65B | 14.0 | 54 | Compare |
|
BCRX
BioCryst Pharmaceuticals Inc
|
$7.68
|
$1.55B | - | 49 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$29.86
|
$1.49B | - | 39 | Compare |
|
AVDL
Avadel Pharmaceuticals plc Ordinary Share
|
$21.64
|
$1.46B | - | 48 | Compare |
|
EVO
Evotec SE American Depositary Shares
|
$1.66
|
$1.34B | - | 29 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.65
|
$1.29B | - | 38 | Compare |
|
AMPH
Amphastar Pharmaceuticals, Inc.
|
$28.87
|
$1.25B | 13.1 | 35 | Compare |
More DVAX Analysis
Data updated: Nov 13, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
44 stocks in this industry